Skip to content

Nitrous oxide

NERVOUS SYSTEM

Also known as: dinitrogen monoxide, dinitrogen oxide, nitrous oxide, usp

FDA approvedATC N01AX13ATC N01AX63

Data last refreshed: (DrugCentral release 2024-11-01)

Key facts

Nitrous oxide is a drug catalogued in DrugCentral.

  • ATC code: N01AX13 (Other general anesthetics).
  • Molecular formula: N2O; molecular weight 44.01 g/mol.

Regulatory approvals (1)

DateAgencyMarketed asApplicantOrphan
—FDA——

ATC classification

ATC codeTherapeutic hierarchy
N01AX13NERVOUS SYSTEM › ANESTHETICS › ANESTHETICS, GENERAL › Other general anesthetics
N01AX63NERVOUS SYSTEM › ANESTHETICS › ANESTHETICS, GENERAL › Other general anesthetics

Reported adverse-event signals

Strongest FDA FAERS disproportionality signals (log-likelihood ratio). A signal is a statistical association in spontaneous reports, not proof that the drug causes the event.

MedDRA termLLR
Anaesthetic complication neurological715.9
Subacute combined cord degeneration581.6
Choroidal infarction307.4
Hyperthermia malignant200.8
Vitamin B12 deficiency154.5
Cardiac arrest147.3
Myelopathy127.3
Bradycardia124.7
Substance use109.0
Drug interaction100.8
Anaesthetic complication96.3
Drug abuse93.5

Chemical structure

Full physicochemical, ADMET and 3D-structure analysis of Nitrous oxide is on its molecule page.

Molecular formulaN2O
Molecular weight44.01 g/mol
CAS number—
InChIKeyGQPLMRYTRLFLPF-UHFFFAOYSA-N
PubChem CID948
[O-][N+]#N

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

What is the chemical formula of Nitrous oxide?

Nitrous oxide has the molecular formula N2O and a molecular weight of 44.01 g/mol.

Browse: all drugs starting with N · drug guides by category · protein targets A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.

Quick facts

Status—
First approval—
AgencyFDA
Targets0
Indications0
FormulaN2O
DrugCentral ID4238
Interactive profile